Skip to main content
. Author manuscript; available in PMC: 2008 Jun 11.
Published in final edited form as: Anesthesiology. 2008 May;108(5):882–887. doi: 10.1097/ALN.0b013e31816c8a8d

Fig. 1.

Fig. 1

Tat peptides were delivered into CNS after intraperitoneal injection. I: PSD-95 PDZ2 (8 mg/kg); II: mutated Tat-PSD-95 PDZ2 (8 mg/kg); III: Tat-PSD-95 PDZ2 (2 mg/kg); IV: Tat-PSD-95 PDZ2 (4 mg/kg); V: Tat-PSD-95 PDZ2 (8 mg/kg). Tubulin served as a loading control. The data shown are representative of three independent experiments (A) and the results after statistical analysis (B). *p < 0.05 vs. group III.